Optimizing home-based long-term intensive care for neurological patients with neurorehabilitation outreach teams - protocol of a multicenter, parallel-group randomized controlled trial (OptiNIV-Study)
- PMID: 35927616
- PMCID: PMC9351064
- DOI: 10.1186/s12883-022-02814-y
Optimizing home-based long-term intensive care for neurological patients with neurorehabilitation outreach teams - protocol of a multicenter, parallel-group randomized controlled trial (OptiNIV-Study)
Abstract
Background: Even with high standards of acute care and neurological early rehabilitation (NER) a substantial number of patients with neurological conditions still need mechanical ventilation and/or airway protection by tracheal cannulas when discharged and hence home-based specialised intensive care nursing (HSICN). It may be possible to improve the home care situation with structured specialized long-term neurorehabilitation support and following up patients with neurorehabilitation teams. Consequently, more people might recover over an extended period to a degree that they were no longer dependent on HSICN.
Methods: This healthcare project and clinical trial implements a new specialised neurorehabilitation outreach service for people being discharged from NER with the need for HSICN. The multicentre, open, parallel-group RCT compares the effects of one year post-discharge specialized outpatient follow-up to usual care in people receiving HSICN. Participants will randomly be assigned to receive the new form of healthcare (intervention) or the standard healthcare (control) on a 2:1 basis. Primary outcome is the rate of weaning from mechanical ventilation and/or decannulation (primary outcome) after one year, secondary outcomes include both clinical and economic measures. 173 participants are required to corroborate a difference of 30 vs. 10% weaning success rate statistically with 80% power at a 5% significance level allowing for 15% attrition.
Discussion: The OptiNIV-Study will implement a new specialised neurorehabilitation outreach service and will determine its weaning success rates, other clinical outcomes, and cost-effectiveness compared to usual care for people in need for mechanical ventilation and/or tracheal cannula and hence HSICN after discharge from NER.
Trial registration: The trial OptiNIV has been registered in the German Clinical Trials Register (DRKS) since 18.01.2022 with the ID DRKS00027326 .
Keywords: Clinical trial; Healthcare; Neurorehabilitation; Protocol; Weaning.
© 2022. The Author(s).
Conflict of interest statement
The authors declare that they have no competing interests. Furthermore, no competing interests are known for the other participating centres.
Figures
References
-
- Oehmichen F, Ketter G, Mertl-Rötzer M, Platz T, Puschendorf W, Rollnik JD, Schaupp M, Pohl M. Beatmungsentwöhnung in neurologischen Weaningzentren: Eine Bestandsaufnahme der Arbeitsgemeinschaft Neurologisch-neurochirurgische Frührehabilitation [Weaning from prolonged mechanical ventilation in neurological weaning units: an evaluation of the German Working Group for early Neurorehabilitation] Nervenarzt. 2012;83(10):1300–1307. doi: 10.1007/s00115-012-3600-z. - DOI - PubMed
-
- Pohl M, Singer M. Airway and ventilation management. In: Platz T, editor. Clinical pathways in stroke rehabilitation. Cham: Springer; 2021. p. 71–83. 10.1007/978-3-030-58505-1_5.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
